Evidence-based stock research on MDLZ. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
MDLZ closed at $61.64 (-0.10%) as of 2026-05-13. Market cap: $79.12B. P/E (trailing) 30.5. Concerns: debt-to-equity of 83.8 — balance-sheet-heavy.. Last quarter: Revenue $10.08B, net income $560.00M, free cash flow $2.85B.
A single reasoning model has blind spots it doesn’t know about. We examine MDLZacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyFree to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MDLZ" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MDLZ brief"></iframe>